Top Clinical Trials companies in Belgium by Net Income Margin

This ranking features the top 4 Clinical Trials companies in Belgium ranked by Net Income Margin, averaging a Net Income Margin of -1,384.84%, for February 07, 2025.

Belgium

Clinical Trials
Net Income Margin
#
Name
Net Income Margin
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
GLPG.AS

Galapagos NV

1

GLPG.AS
88.31%
Dec. 31, 2023 USD 23.14 1.75%

Belgium
2
MDXH

MDxHealth SA

2

MDXH
-61.40%
Dec. 31, 2023 USD 1.91 0.00%

Belgium
3
NYXH

Nyxoah S.A.

3

NYXH
-993.84%
Dec. 31, 2023 USD 10.80 2.86%

Belgium
4
SEQUA.BR

Sequana Medical NV

4

SEQUA.BR
-4,572.42%
Dec. 31, 2023 USD 2.20 -1.56%

Belgium
Frequently Asked Questions
  • Which Clinical Trials company in Belgium has the highest Net Income Margin ?

    The Clinical Trials company in Belgium with the highest Net Income Margin is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at 88.31%.

  • Which Clinical Trials company in Belgium has the lowest Net Income Margin ?

    The Clinical Trials company in Belgium with the lowest Net Income Margin is Sequana Medical NV (Brussels Stock Exchange: SEQUA.BR) at -4,572.42%.

SV Wall Street